Skip to main content

Advertisement

Table 1 Clinical profiles of the study population

From: Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation

Variables Sinus rhythm (n = 77) Atrial fibrillation (n = 76) p value
Age (years) 65.68 ± 9.24 65.34 ± 8.93 0.817
Gender (male) 36 (46.8%) 39 (51.3%) 0.572
Hypertension (%) 36 (36.8%) 37 (48.7%) 0.811
Diabetes mellitus (%) 14 (18.2%) 22 (28.9%) 0.117
Coronary artery disease (%) 8 (10.4%) 9(11.8%) 0.775
Left atrial diameter (mm) 35.33 ± 5.86 39.86 ± 5.35 < 0.001
Left ventricular end-diastolic diameter (mm) 45.34 ± 5.10 46.42 ± 3.92 0.270
Left ventricular end-systolic diameter (mm) 27.55 ± 3.32 28.04 ± 3.26 0.359
Left ventricular ejection fraction (%) 69.13 ± 4.97 69.17 ± 5.98 0.979
NT-proBNP (pg/ml) 113.42 ± 30.15 213.85 ± 85.76 < 0.001
  1. Data were expressed as numbers (%), Mean ± SD.
  2. Abbreviations: NT-proBNP = N-terminal pro-brain natriuretic peptide.